Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | CCL2 | P13500 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29433715 | 1.00 | HTR2A (0.38) | HTR2ACYP2D6MAOAMAOBKDM4E | |
| SCHEMBL4393423 | 0.82 | MAOA (0.33) | MAOAMAOB | |
| SCHEMBL9817817 | 0.77 | MAOA (0.38) | HTR2ACYP2D6MAOAMAOBMEN1 | |
| SCHEMBL2006251 | 0.74 | HTR2A (0.42) | HTR2ACYP2D6KDM4EBRD4CCL2 | |
| SCHEMBL16398711 | 0.74 | HTR2A (0.38) | HTR2ACYP2D6KDM4EBRD4CCL2 | |
| SCHEMBL292481 | 0.74 | BRD4 (0.38) | HTR2ACYP2D6KDM4EBRD4CCL2 | |
| SCHEMBL292479 | 0.74 | HTR2A (0.38) | HTR2ACYP2D6KDM4EBRD4CCL2 | |
| SCHEMBL28793125 | 0.74 | HTR2A (0.34) | HTR2ACYP2D6KDM4EBRD4CCL2 | |
| SCHEMBL9934350 | 0.74 | HTR2A (0.38) | HTR2ACYP2D6KDM4ELMNATP53 | |
| SCHEMBL299075 | 0.72 | EDNRA (0.37) | HTR2ACYP2D6BRD4CCL2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1182183-B1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES MADE BY USING THE SAME | IDEMITSU KOSAN CO (JP) | 2009-12-09 | — | — | EP | claimed |
| EP-4678189-A2 | CANNABINOID COMPOSITIONS AND METHODS OF USING | Greenway Herbal Products, LLC (US) | 2026-01-14 | — | — | EP | disclosed |
| US-20200289458-A1 | TOPICAL FORMULATIONS OF CANNABINOIDS AND USE THEREOF IN THE TREATMENT OF PAIN | INMED PHARMACEUTICALS INC (CA) | 2020-09-17 | — | — | US | disclosed |
| EP-1182183-B1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES MADE BY USING THE SAME | IDEMITSU KOSAN CO (JP) | 2009-12-09 | — | — | EP | disclosed |
| CN-1754877-A | Anthracene derivative and electroluminescent device using the same | IDEMITSU KOSAN CO (JP) | 2006-04-05 | — | — | CN | disclosed |
| CN-1226250-C | Anthracene derivative and electroluminescent device using the same | IDEMITSU KOSAN CO (JP) | 2005-11-09 | — | — | CN | disclosed |
| US-6797848-B2 | Anthracene derivative and organic electroluminescence device using the derivative | IDEMITSU KOSAN, LTD. (JP) | 2004-09-28 | — | — | US | disclosed |
| US-20040100188-A1 | Anthracene derivative and organic electroluminescence device using the derivative | IDEMITSU KOSAN CO., LTD. (JP) | 2004-05-27 | — | — | US | disclosed |
| CN-1365347-A | Anthracene derivative and electroluminescent device using the same | IDEMITSU KOSAN CO (JP) | 2002-08-21 | — | — | CN | disclosed |
| US-20020048687-A1 | Anthracene derivative and organic electroluminescence device using the derivative | IDEMITSU KOSAN CO., LTD. (JP) | 2002-04-25 | — | — | US | disclosed |
| EP-1182183-A1 | ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES MADE BY USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2002-02-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040100188-A1 | Anthracene derivative and organic electroluminescence device using the derivative | ACIN1, KCNQ1, LBR | HTR2A 4021/4885CYP2D6 1152/4885MAOA 1621/4885 |
| US-20200289458-A1 | TOPICAL FORMULATIONS OF CANNABINOIDS AND USE THEREOF IN THE TREATMENT OF PAIN | CNR2, CNR1, LCAT | HTR2A 2548/4885CYP2D6 1444/4885MAOA 4769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.